QS/1 announces partnership with CCNC

SPARTANBURG, S.C. — QS/1 announced a partnership with Community Care of North Carolina in an effort to coordinate healthcare providers. QS/1’s Pharmacy Management Systems have been upgraded to exchange data with CCNC’s PharmaceHome, a software application that conducts medication reconciliation to manage the care of Medicaid recipients in North Carolina, QS/1 stated.

“Patients no longer see one doctor,” said Michael Ziegler, QS/1 senior manager, marketing and analyst. “Patients also consult with specialists, nurse practitioners and pharmacists about their health. That is why this collaboration with CCNC is crucial.”

According to Ziegler, healthcare providers can review and update the records of patients each time they receive care. “Participating pharmacies can then access this data to view a complete picture of patient medication adherence,” he said.

PharmaceHome was developed as part of a grant from the Office of the National Coordinator. Community pharmacies in N.C. will use the database to document activities that make up a Comprehensive Medication Review. This will follow up on issues related to drug therapy problems, QS/1 said.

“QS/1 is pleased to see CCNC work on an effort that focuses on the benefits community pharmacy brings to healthcare and to find ways to reimburse pharmacies for this value,” Ziegler said.

NACDS names new officers for 2015-2016

PALM BEACH, Fla. — The National Association of Chain Drug Stores announced during its Annual Meeting, the election of new officers, four new executive committee members and five new board of directors member for the coming year.

Randy Edeker, chairman, president and chief executive officer of Hy-Vee will serve as the new NACDS chairman of the board of directors. Edeker succeeds John Standley, chairman and chief executive officer of Rite Aid.

In addition, Martin Otto, chief merchant and CFO of H-E-B, was elected vice chairman, and J.K. Symancyk, president of Meijer, was elected treasurer. Each officer will serve a one-year term.

“I congratulate Randy Edeker on his election as NACDS chairman of the Board of Directors,” said NACDS president and CEO Steven Anderson, IOM, CAE. “During his service on the Executive Committee, Randy’s leadership helped drive NACDS’ activities on key industry issues and policies. His extraordinary leadership at Hy-Vee has driven continued success and further illustrates his commitment to the industry. We look forward to working with him in his new role with NACDS in the coming year.”

The NACDS Board also elected the following new executive committee members: Labeed Diab, president of health and wellness with Walmart; Alex Gourlay, president of Walgreens; Martin Otto, chief merchant and CFO of H-E-B; and J.K. Symancyk, president of Meijer.

The five new board of directors members, who were elected to serve three-year terms, include: Richard Ashworth, president, pharmacy and retail operations with Walgreens ; Helena Foulkes, president, CVS/pharmacy and EVP, CVS Caremark, with CVS Health; Jon Giacomin, CEO, pharmaceutical segment with Medicine Shoppe International; Alex Gourlay, president of Walgreen Co.; and David Neu, president, Good Neighbor Pharmacy.

Mylan to commence with formal offer to acquire Perrigo

POTTERS BAR, England — Mylan announced on Friday that it commence with a formal offer to acquire generic drug maker Perrigo.

Under the terms of the offer announced Friday, Perrigo shareholders will receive $60 in cash and 2.2 Mylan ordinary shares for each Perrigo ordinary share. The formal offer is worth about $33 billion in cash and stock.

It is expected that, following the consummation of the transaction, Mylan shareholders will own approximately 61.8% of the outstanding Mylan ordinary shares on a fully diluted basis and former Perrigo shareholders will own approximately 38.2% of the outstanding Mylan ordinary shares on a fully diluted basis.

So far, Perrigo has rejected Mylan’s advances. Earlier in the week, Perrigo unanimously rejected the unsolicited proposal from Mylan, disclosed April 8, to acquire all of the outstanding shares of Perrigo for $205 per share in a deal valued at $29 billion.

"While we are disappointed by the decision of the Perrigo Board to reject our proposal without entering into discussions thus far, we are still hopeful and confident that we can engage with their Board about our offer and how to best bring our organizations together,” stated Mylan's executive chairman Robert Coury. "As evidenced by today's Rule 2.5 announcement, we remain steadfast in our offer to acquire Perrigo, given the substantial opportunities we anticipate it will create for our company, shareholders and other stakeholders. We will not be distracted from the pursuit of this exciting, value-creating combination."

Mylan expects the combination will result in at least $800 million of annual pre-tax operational synergies by the end of year four following the consummation of the offer.

Meanwhile, Mylan shareholders have another deal to consider: Teva Pharmaceutical Industries recently submitted an unsolicited proposal to acquire Mylan in a deal valued at $40 billion.

RELATED NEWS

The workshops, sponsored by McKesson, have been offered by the Alexandria, Va.-based organization for more than 20 years and are slated to take place June 8-10 in Denver, Colo., and Oct. 4-6 in Boston.

Forgotten Password

Registration complete

REGISTER

USERNAME *

Spaces are allowed; punctuation is not allowed except for periods, hyphens, and underscores.

E-MAIL ADDRESS *

A valid e-mail address. All e-mails from the system will be sent to this address. The e-mail address is not made public and will only be used if you wish to receive a new password or wish to receive certain news or notifications by e-mail.

Password *

Confirm Password *

Please choose a password for your account; it must be 8 - 30 characters. .

First Name *

Last Name *

Company Name *

Job Title *

ZIP *

Country *

Are you a *

Retailer or Healthcare professional

Non-Retailer

How many stores do you operate?: *

Which best describes the business/industry you work in?: *

Which best describes your job title?: *

Please select the newsletters you would like to subscribe to

DSN A.M.
Daily news stories covering the retail drug industry

Breaking News
First-to-the-market with developing stories in the industry